APA (7th ed.) Citation

Manickam, R., Santhana, S., Xuan, W., Bisht, K. S., & Tipparaju, S. M. (2025). Nampt: A new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases. Canadian Journal of Physiology & Pharmacology, 103(7), 208. https://doi.org/10.1139/cjpp-2024-0400

Chicago Style (17th ed.) Citation

Manickam, Ravikumar, Sandhya Santhana, Wanling Xuan, Kirpal S. Bisht, and Srinivas M. Tipparaju. "Nampt: A New Therapeutic Target for Modulating NAD+ Levels in Metabolic, Cardiovascular, and Neurodegenerative Diseases." Canadian Journal of Physiology & Pharmacology 103, no. 7 (2025): 208. https://doi.org/10.1139/cjpp-2024-0400.

MLA (9th ed.) Citation

Manickam, Ravikumar, et al. "Nampt: A New Therapeutic Target for Modulating NAD+ Levels in Metabolic, Cardiovascular, and Neurodegenerative Diseases." Canadian Journal of Physiology & Pharmacology, vol. 103, no. 7, 2025, p. 208, https://doi.org/10.1139/cjpp-2024-0400.